Lv1
4 积分 2026-09-28 加入
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
13小时前
待确认
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
15小时前
已完结
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
15小时前
已完结
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
16小时前
已关闭
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
16小时前
已完结
皖公网安备34019202002308
